Platelet-albumin-bilirubin versus albumin–bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resection

Abstract Background The Child–Pugh (CP) score is widely used to evaluate the severity of liver dysfunction in patients with hepatocellular carcinoma (HCC). Recently, both the albumin-bilirubin (ALBI) and platelet-albumin-bilirubin (PALBI) grade have been raised to be objective measurement indexes of...

Full description

Saved in:
Bibliographic Details
Main Authors: Haojie Yang, Shuang Shen, Yuting Yang, Houping Zhou, Bangde Xiang
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-14240-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849725345838661632
author Haojie Yang
Shuang Shen
Yuting Yang
Houping Zhou
Bangde Xiang
author_facet Haojie Yang
Shuang Shen
Yuting Yang
Houping Zhou
Bangde Xiang
author_sort Haojie Yang
collection DOAJ
description Abstract Background The Child–Pugh (CP) score is widely used to evaluate the severity of liver dysfunction in patients with hepatocellular carcinoma (HCC). Recently, both the albumin-bilirubin (ALBI) and platelet-albumin-bilirubin (PALBI) grade have been raised to be objective measurement indexes of liver function which can sufficiently stratify HCC patient survival. In this study, we aim to compare the ability of albumin-bilirubin (ALBI) and platelet-albumin-bilirubin (PALBI) grade to predict outcomes in hepatitis B-Induced HCC after liver resection with curative intent. Methods Between April 2013 and April 2023, 1005 consecutive hepatitis B-Induced HCC patients who underwent liver resection were included in this study. The performance of PALBI and ALBI score in predicting long-term survival was evaluated. Results The area under the ROC curve (AUC) of the PALBI(AUC:0.618) for predicting long-term survival was greater than that of the ALBI(AUC:0.522). In the multivariate analysis for OS, both the ALBI (HR: 1.246 95%CI: 1.029–1.508 P = 0.024) and PALBI (HR: 1.207 95%CI: 1.049–1.388 P = 0.009) scores were identified as independent predictors of OS in HCC patients. In the univariate analysis for DFS, the PALBI grade was also significantly associated with poor DFS (P = 0.041). In contrast, the ALBI grade was not found to be significantly associated with poor DFS (P = 0.414). Subgroup analysis also showed, among patients across each BCLC stage, the group with ALBI grade 1 had DFS similar to that of the group with ALBI grade 2 (both P > 0.05). However, the PALBI grade can differentiate each BCLC stages into three prognostic groups (all P < 0.05). Conclusion Compared to ALBI grade, the PALBI grade is more clinically feasible and has better prognostic ability regardless of the grade of BCLC stage.
format Article
id doaj-art-78b725dffabd4454b3fbd1cfc8ec24b4
institution DOAJ
issn 1471-2407
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-78b725dffabd4454b3fbd1cfc8ec24b42025-08-20T03:10:30ZengBMCBMC Cancer1471-24072025-05-012511810.1186/s12885-025-14240-7Platelet-albumin-bilirubin versus albumin–bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resectionHaojie Yang0Shuang Shen1Yuting Yang2Houping Zhou3Bangde Xiang4Department of Hepatobiliary Surgery, Guangxi Medical University Cancer HospitalDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer HospitalDepartment of Oncology, Changde Hospital (The First People’s Hospital of Changde City), Xiangya School of Medicine, Central South UniversityDepartment of Hepatobiliary Surgery, Changde Hospital (The First People’s Hospital of Changde City), Xiangya School of Medicine, Central South UniversityDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer HospitalAbstract Background The Child–Pugh (CP) score is widely used to evaluate the severity of liver dysfunction in patients with hepatocellular carcinoma (HCC). Recently, both the albumin-bilirubin (ALBI) and platelet-albumin-bilirubin (PALBI) grade have been raised to be objective measurement indexes of liver function which can sufficiently stratify HCC patient survival. In this study, we aim to compare the ability of albumin-bilirubin (ALBI) and platelet-albumin-bilirubin (PALBI) grade to predict outcomes in hepatitis B-Induced HCC after liver resection with curative intent. Methods Between April 2013 and April 2023, 1005 consecutive hepatitis B-Induced HCC patients who underwent liver resection were included in this study. The performance of PALBI and ALBI score in predicting long-term survival was evaluated. Results The area under the ROC curve (AUC) of the PALBI(AUC:0.618) for predicting long-term survival was greater than that of the ALBI(AUC:0.522). In the multivariate analysis for OS, both the ALBI (HR: 1.246 95%CI: 1.029–1.508 P = 0.024) and PALBI (HR: 1.207 95%CI: 1.049–1.388 P = 0.009) scores were identified as independent predictors of OS in HCC patients. In the univariate analysis for DFS, the PALBI grade was also significantly associated with poor DFS (P = 0.041). In contrast, the ALBI grade was not found to be significantly associated with poor DFS (P = 0.414). Subgroup analysis also showed, among patients across each BCLC stage, the group with ALBI grade 1 had DFS similar to that of the group with ALBI grade 2 (both P > 0.05). However, the PALBI grade can differentiate each BCLC stages into three prognostic groups (all P < 0.05). Conclusion Compared to ALBI grade, the PALBI grade is more clinically feasible and has better prognostic ability regardless of the grade of BCLC stage.https://doi.org/10.1186/s12885-025-14240-7PALBIALBIHepatocellular carcinomaLiver functionPrognosis
spellingShingle Haojie Yang
Shuang Shen
Yuting Yang
Houping Zhou
Bangde Xiang
Platelet-albumin-bilirubin versus albumin–bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resection
BMC Cancer
PALBI
ALBI
Hepatocellular carcinoma
Liver function
Prognosis
title Platelet-albumin-bilirubin versus albumin–bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resection
title_full Platelet-albumin-bilirubin versus albumin–bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resection
title_fullStr Platelet-albumin-bilirubin versus albumin–bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resection
title_full_unstemmed Platelet-albumin-bilirubin versus albumin–bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resection
title_short Platelet-albumin-bilirubin versus albumin–bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resection
title_sort platelet albumin bilirubin versus albumin bilirubin as a predictor of long term survival for hepatitis b induced hepatocellular carcinoma after hepatic resection
topic PALBI
ALBI
Hepatocellular carcinoma
Liver function
Prognosis
url https://doi.org/10.1186/s12885-025-14240-7
work_keys_str_mv AT haojieyang plateletalbuminbilirubinversusalbuminbilirubinasapredictoroflongtermsurvivalforhepatitisbinducedhepatocellularcarcinomaafterhepaticresection
AT shuangshen plateletalbuminbilirubinversusalbuminbilirubinasapredictoroflongtermsurvivalforhepatitisbinducedhepatocellularcarcinomaafterhepaticresection
AT yutingyang plateletalbuminbilirubinversusalbuminbilirubinasapredictoroflongtermsurvivalforhepatitisbinducedhepatocellularcarcinomaafterhepaticresection
AT houpingzhou plateletalbuminbilirubinversusalbuminbilirubinasapredictoroflongtermsurvivalforhepatitisbinducedhepatocellularcarcinomaafterhepaticresection
AT bangdexiang plateletalbuminbilirubinversusalbuminbilirubinasapredictoroflongtermsurvivalforhepatitisbinducedhepatocellularcarcinomaafterhepaticresection